Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions

Lupus

Volumn 17, Issue 4, 2008, Pages 329-331

  Marzano, Angelo Valerio ^a,c   Ramoni, S ^a   Del Papa, N ^b   Barbareschi, M ^a   Alessi, E ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Department of Rheumatology H G Pini ^*  (Italy)

^c Institute of Dermatological Sciences   (Italy)

Author keywords

Ankylosing spondylitis; Erythema multiforme; Leflunomide; Lupus erythematosus

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; ROFECOXIB; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CASE REPORT; DRUG DOSE INCREASE; DRUG EFFECT; DRUG WITHDRAWAL; ERYTHEMA MULTIFORME; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; RASH; SKIN LUPUS ERYTHEMATOSUS;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIBODIES, ANTINUCLEAR; BIOPSY; DIAGNOSIS, DIFFERENTIAL; ERYTHEMA MULTIFORME; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; LUPUS ERYTHEMATOSUS, CUTANEOUS; SKIN; SPONDYLITIS, ANKYLOSING;

EID: 43249112538     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307087189     Document Type: Article

References (13)

1. Strand, V, Cohen, S, Schiff, M, et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 1999; 159: 2542-2550.
2. Holm, EA, Balslev, E, Jemec, GBE. Vasculitis occurring during leflunomide therapy. Dermatology 2001; 203: 258-259.
3. Kerr, OA, Murray, CS, Tidman, MJ. Subacute cutaneous lupus erythematosus associated with leflunomide. Clin Exp Dermatol 2004; 29: 319-320.
4. Chan, SK, Hazleman, BL, Burrows, NP. Subacute cutaneous lupus erythematosus precipitated by leflunomide. Clin Exp Dermatol 2005; 30: 724-725.
5. Elias, MAJ, Tam, CC, David-Bajar, KMD. Subacute cutaneous lupus erythematosus associated with leflunomide. Cutis 2005; 76: 189-192.
6. Goëb, V, Berthelot, JM, Joly, P, et al. Leflunomide-induced subacute cutaneous lupus erythematosus. Rheumatology 2005; 44: 823-824.
7. Gensburger, D, Kawashima, M, Marotte, H, Kanitakis, J, Miossec, P. Lupus erythematosus with leflunomide: induction or reactivation? Ann Rheum Dis 2005; 64: 153-155.
8. Breedveld, FC, Dayer, JM. Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis 2000; 59: 841-849.
9. Sontheimer, RD. Subacute lupus erythematosus: a decade's prospective. Med Clin N Am 1989; 73: 1073-1090.
10. Marzano, AV, Berti, E, Gasparini, G, Caputo, R. Lupus erythematosus with antiphospholipid syndrome and erythema multiforme-like lesions. Br J Dermatol 1999; 141: 720-724.
11. Aydogan, K, Karadogan, SK, Balaban Adim, S, Tunali, S. Lupus erythematosus associated with erythema multiforme: report of two cases and review of the literature. J Eur Acad Dermatol Venereol 2005; 19: 621-627.
12. Alaibac, M, Berti, E, Chizzolini, C, et al. Role of cellular immunity in the pathogenesis of autoimmune skin diseases. Clin Exp Rheumatol 2006; 24: S14-S19.
13. Sarzi-Puttini, P, Atzeni, F, Capsoni, F, Lubrano, E, Doria, A. Drug-induced lupus erythematosus. Autoimmunity 2005, 38: 507-518.